Trial reportBMC anesthesiology2025
Quality of early recovery after ultrasound-guided serratus plane block for transapical transcatheter aortic valve implantation surgery under general anesthesia: a single-center randomized controlled trial.
Trial report in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
ΑBSTRACT:
backgroundRegional anesthesia techniques, including the serratus anterior plane block (SAPB), reduce postoperative pain after minimally invasive cardiac surgery. However, the evidence regarding its impact on transapical transcatheter aortic valve replacement (TA-TAVR) is limited, and data specifically exploring its effectiveness on patient-centric outcomes are lacking.
methodsWe conducted a single-center randomized controlled trial comparing the efficacy of ultrasound-guided SAPB with ropivacaine 0.5% (40 ml) with no block for patients undergoing TA-TAVR. The primary outcome was 24-hour Quality of Recovery-40 (QoR-40) score. Secondary outcomes included QoR-40 at 48 h, pain scores, opioid consumption, and complications.
resultsA total of 66 participants were included in the analysis. The median QoR-40 [IQR] at 24 h was higher in SAPB group (n = 32) compared with the no block group (n = 34): 180.5 (171.25–183) VS 172 (165.25–179), p = 0.006. At 48 h, scores were 185.5 (182–189) vs. 183.5 (178.5–187), p = 0.048. Although these differences were statistically significant, they did not reach the minimum clinically important difference (MCID) of 6.3. Early postoperative analgesia was superior in the SAPB group, with lower resting/coughing NRS scores at 6 and 12 h (median difference 1, P < 0.001). However, there were no intergroup differences in opioid consumption or the need for rescue analgesia.
conclusionsAs part of multimodal analgesia for TA-TAVR, SAPB improved early postoperative analgesia but did not enhance the multidimensional quality of early recovery, as measured by the QoR-40 score. Further studies are warranted.
trial registrationChiCTR2300068584. Registered 24 February 2023. https://www.chictr.org.cn/bin/project/edit? pid=184719 .
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.